During the last session, Vivos Therapeutics Inc (NASDAQ:VVOS)’s traded shares were 81189.0, with the beta value of the company hitting 7.18. At the end of the trading day, the stock’s price was $2.10, reflecting an intraday gain of 0.96% or $0.02. The 52-week high for the VVOS share is $6.28, that puts it down -199.05 from that peak though still a striking 9.05% gain since the share price plummeted to a 52-week low of $1.91. The company’s market capitalization is $12.37M, and the average intraday trading volume over the past 10 days was 92440.0 shares, and the average trade volume was 148.93K shares over the past three months.
Vivos Therapeutics Inc (NASDAQ:VVOS) trade information
Vivos Therapeutics Inc (VVOS) registered a 0.96% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.96% in intraday trading to $2.10, hitting a weekly high. The stock’s 5-day price performance is -8.30%, and it has moved by -40.51% in 30 days. Based on these gigs, the overall price performance for the year is -22.22%. The short interest in Vivos Therapeutics Inc (NASDAQ:VVOS) is 0.29 million shares and it means that shorts have 3.72 day(s) to cover.
Vivos Therapeutics Inc (VVOS) estimates and forecasts
In the rating firms’ projections, revenue will increase 15.10% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3.67M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 4.2M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 3.42M and 4.05M respectively. In this case, analysts expect current quarter sales to grow by 7.24% and then jump by 3.49% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.77%. While earnings are projected to return 42.79% in 2025.
VVOS Dividends
Vivos Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Vivos Therapeutics Inc (NASDAQ:VVOS)’s Major holders
Vivos Therapeutics Inc insiders own 8.00% of total outstanding shares while institutional holders control 12.00%, with the float percentage being 13.05%.
